Latest Channelopathy Stories
Claire Wineland receives notable award for her dedication to making a difference in the lives of others living with cystic fibrosis Los Angeles, CA (PRWEB) September
Expanded Collaboration Supports Phase 2 Clinical Trial Initiation of First-In-Class ENaC Inhibitor for the Treatment of Cystic Fibrosis DURHAM, N.C., Sept.
- Recipients will compete for public votes for a chance to win one of two Thriving Undergraduate and Graduate Scholar awards NORTH CHICAGO, Ill., Aug.
Cystic fibrosis continues to be devastating for many people around the world.
- AbbVie will donate $10 to Cystic Fibrosis Research, Inc. (CFRI) for every recipe collected between August 1 and September 15, 2014, up to $10,000 NORTH CHICAGO, Ill.
The study, led by Martina Gentzsch, PhD, provides evidence that could help drug developers improve compounds aimed at correcting CFTR proteins in cystic fibrosis patients.
ReportsnReports.com adds “OpportunityAnalyzer: Cystic Fibrosis - Opportunity Analysis and Forecasts to 2018 – Event-Driven Update” to its store.
Los Angeles teen, Claire Wineland, receives prestigious award for her foundation’s dedication to making a difference in the lives of others living with cystic fibrosis. Los
A genetic variant linked to sudden cardiac death leads to protein overproduction in heart cells.
LONDON, May 26, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
Cystic fibrosis, also called mucoviscidosis, is an autosomal recessive genetic disorder of the viscous secretions in the body. In turn, it effects the lungs, pancreas, liver, and intestines, as well as all other exocrine glands in the body. The most common genetic mutation that causes CF is a deletion of three nucleotides that results in a loss of phenylalanine, an amino acid at the 508th position on the protein. It should be noted, however, that there are over a thousand other mutations that...
- An armed gangster.